Quick Answer
Galera Therapeutics, Inc. reported Net Income of $149.05 million for fiscal year 2025.
Galera Therapeutics, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | $149.05M | +886.2% |
| 2024 | -$18.96M | +67.9% |
| 2023 | -$59.08M | +5.0% |
| 2022 | -$62.22M | +22.7% |
| 2021 | -$80.53M | -8.5% |
| 2020 | -$74.22M | -42.9% |
| 2019 | -$51.93M | -119.3% |
| 2018 | -$23.68M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$1.39M | +75.1% | -29.1% |
| June 30, 2025 | -$1.07M | +73.5% | +32.5% |
| March 31, 2025 | -$1.59M | +63.7% | +71.5% |
| September 30, 2024 | -$5.58M | +63.0% | -37.3% |
| June 30, 2024 | -$4.06M | +80.4% | +7.2% |
| March 31, 2024 | -$4.38M | +75.3% | +70.9% |
| September 30, 2023 | -$15.07M | +6.0% | +27.2% |
| June 30, 2023 | -$20.71M | -42.3% | -17.0% |
- Galera Therapeutics, Inc. showed an increase of +886.2% in Net Income compared to the prior fiscal year.
- Over the 2018–2025 period, Galera Therapeutics, Inc.’s net income has grown by 729.5% (from -$23.68 million to $149.05 million).
- The most recent figure is from Galera Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: